These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26611175)

  • 21. Neurocognitive function in HIV infected patients on antiretroviral therapy.
    Winston A; Arenas-Pinto A; Stöhr W; Fisher M; Orkin CM; Aderogba K; De Burgh-Thomas A; O'Farrell N; Lacey CJ; Leen C; Dunn D; Paton NI;
    PLoS One; 2013; 8(4):e61949. PubMed ID: 23646111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?
    Moulignier A; Viret-Vilayphon AC; Lescure FX; Plaisier E; Salomon L; Lamirel C; Pialoux G;
    J Neurol; 2020 May; 267(5):1368-1376. PubMed ID: 31980868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    Loubet P; Charpentier C; Visseaux B; Borbor A; Nuta C; Adu E; Chapplain JM; Baysah M; Tattevin P; Yazdanpanah Y; Descamps D
    J Antimicrob Chemother; 2015; 70(6):1881-4. PubMed ID: 25698771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
    Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
    Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
    Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
    Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
    Sharma S; Schlusser KE; de la Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; Neaton JD; Laeyendecker O;
    AIDS; 2019 Jul; 33(8):1335-1344. PubMed ID: 31157663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    Soulie C; Grudé M; Descamps D; Amiel C; Morand-Joubert L; Raymond S; Pallier C; Bellecave P; Reigadas S; Trabaud MA; Delaugerre C; Montes B; Barin F; Ferré V; Jeulin H; Alloui C; Yerly S; Signori-Schmuck A; Guigon A; Fafi-Kremer S; Haïm-Boukobza S; Mirand A; Maillard A; Vallet S; Roussel C; Assoumou L; Calvez V; Flandre P; Marcelin AG;
    J Antimicrob Chemother; 2017 Aug; 72(8):2351-2354. PubMed ID: 28472307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy.
    Koethe JR; Jenkins CA; Petucci C; Culver J; Shepherd BE; Sterling TR
    Medicine (Baltimore); 2016 May; 95(19):e3634. PubMed ID: 27175676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls.
    Cohen S; Ter Stege JA; Geurtsen GJ; Scherpbier HJ; Kuijpers TW; Reiss P; Schmand B; Pajkrt D
    Clin Infect Dis; 2015 Apr; 60(7):1111-9. PubMed ID: 25516183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
    Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
    N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive trajectories after treatment in acute HIV infection.
    Chan P; Kerr SJ; Kroon E; Colby D; Sacdalan C; Hellmuth J; Reiss P; Vasan S; Ananworanich J; Valcour V; Spudich S; Paul R;
    AIDS; 2021 May; 35(6):883-888. PubMed ID: 33534200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
    Muñoz-Moreno JA; Prats A; Moltó J; Garolera M; Pérez-Álvarez N; Díez-Quevedo C; Miranda C; Fumaz CR; Ferrer MJ; Clotet B;
    PLoS One; 2017; 12(8):e0182547. PubMed ID: 28854283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive Performance and Frailty in Older HIV-Positive Adults.
    Paul RH; Cooley SA; Garcia-Egan PM; Ances BM
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):375-380. PubMed ID: 29957675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect.
    Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR;
    J Neurovirol; 2013 Aug; 19(4):383-92. PubMed ID: 23943468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy.
    Schouten J; Su T; Wit FW; Kootstra NA; Caan MW; Geurtsen GJ; Schmand BA; Stolte IG; Prins M; Majoie CB; Portegies P; Reiss P;
    AIDS; 2016 Apr; 30(7):1027-38. PubMed ID: 26752277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
    Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
    J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.